Papathanassiou Miltiadis, Nikita Eleni, Theodossiadis Panagiotis, Theodossiadis George P, Vergados Ioannis
Department of Ophthalmology, Attikon University Hospital, Athens, Greece.
Cutan Ocul Toxicol. 2010 Sep;29(3):209-11. doi: 10.3109/15569521003775013.
We report a case of corneal epithelial changes that occurred as ocular side effects of treatment with exemestane, a selective steroidal aromatase inhibitor. A 55-year-old woman presented to our outpatient department for routine eye examination. Clinical examination revealed bilateral corneal gray-white bands appearing as intraepithelial microcysts. Her past medical history included breast cancer, for which she underwent chemotherapy and subsequent treatment with exemestane. She was followed up for 1 year, during which the clinical picture of the cornea remained unchanged in both eyes and visual acuity remained unaffected. A causal connection seems to be possible between systemic treatment with exemestane and persisting corneal intraepithelial cysts.
我们报告一例角膜上皮改变,其作为选择性甾体芳香化酶抑制剂依西美坦治疗的眼部副作用出现。一名55岁女性到我们门诊进行常规眼科检查。临床检查发现双侧角膜灰白色条纹,表现为上皮内微囊肿。她既往有乳腺癌病史,为此接受了化疗及后续依西美坦治疗。对她进行了1年的随访,在此期间双眼角膜的临床表现保持不变,视力也未受影响。依西美坦的全身治疗与持续存在的角膜上皮囊肿之间似乎可能存在因果关系。